Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Zoe (health science company)

Zoe (health science company)

Zoe is a Boston and London-based company which builds software for tracking individuals' nutrition response patterns, as well as a mobile application for tracking COVID-19 symptoms.

Zoe is a Boston and London-based company which builds software for tracking individuals' nutrition response patterns, as well as a mobile application for tracking COVID-19 symptoms.

Nutrition response tracking

Zoe working with scientists and thousands of volunteers – combining large-scale data and machine learning to predict personal nutritional responses to any meal. The company says it is working with some of the world’s leading scientists from academic centers including Harvard, Lund (Sweden), Massachusetts General Hospital, Oxford (UK), King’s College London (UK), Tufts and Stanford.

The company uses blood tests and stick-on glucose monitors (originally developed for people with diabetes) to see how the levels of chemicals such as fat, insulin and sugar change in each person’s bloodstream after eating a set of identical standardized foods and their own regular meals. We also gather data on activity, sleep, hunger and gut bacteria (microbiome).

The company intends to use this data to build machine learning models to figure out what’s going on when people eat specific foods and predict with high accuracy how they’ll respond to any meal.

COVID-19 Response

In response to the COVID-19 pandemic, Zoe developed and launched a COVID symptom tracker, which was created by doctors and scientists at Massachusetts General Hospital, the Harvard T.H. Chan School of Public Health, King's College London and Stanford University School of Medicine.

Zoe publishes COVID-19 symptom data for the United Kingdom on its website.The company announced on March 28, 2020 that it had gathered data from over 1 million volunteer contributors.

Timeline

May 5, 2021
Zoe raises a $53,000,000 series B round.
May 4, 2021
Zoe raises $20,000,000 in Series B round, bringing the total raised to $53,000,000. The round led by Ahren Innovation Capital.
February 2019
Zoe raises a $19,000,000 series A round from Accomplice and daphni.
August 2018
Zoe raises a $8,000,000 seed round from Tim Kendall.
August 7, 2017
Zoe was founded by George Hadjigeorgiou, Jonathan Wolf and Tim Spector.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

Overview of The ZOE Scientific Project For Researchers & Clinicians

Whitepaper

Personal metabolic responses to food predicted using

multi-omics machine learning in 1,010 twins and

singletons: The PREDICT I Study

Dr. Sarah Berry

Presentation

Postprandial lipemia and CVD Does the magnitude, peak concentration or duration impact intermediary cardiometabolic risk factors differentially?

Dr. Sarah Berry

Presentation

Predicting personal metabolic responses to food

using multi-omics machine learning in over 1000

twins and singletons from the UK and US:

The PREDICT 1 Study

Tim Spector

Presentation

References

Golden logo
By using this site, you agree to our Terms & Conditions.